111, Inc. (YI)
6.52
-0.32
(-4.68%)
USD |
NASDAQ |
Mar 18, 14:09
111 EPS Diluted (Quarterly) : -0.2081 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Zai Lab Ltd. | -0.4578 |
| Dr. Reddy's Laboratories Ltd. | 0.1627 |
| Concord Medical Services Holdings Ltd. | -- |
| Sinovac Biotech Ltd. | -- |
| CASI Pharmaceuticals, Inc. | -0.6781 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -2.105M |
| Revenue (Quarterly) | 419.25M |
| Total Expenses (Quarterly) | 421.07M |
| Enterprise Value | 136.53M |
| Gross Profit Margin (Quarterly) | 5.93% |
| Profit Margin (Quarterly) | -0.50% |
| Earnings Yield | -17.17% |
| Normalized Earnings Yield | -17.17 |